These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3188734)

  • 1. [Interserovar antitoxic immunity to Vibrio cholerae toxins].
    Belov LG; Adamov AK; Avrorov VP; Kulikova VL; Glian'ko EV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jul; (7):43-6. PubMed ID: 3188734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection.
    Lycke N; Svennerholm AM; Holmgren J
    Microb Pathog; 1986 Aug; 1(4):361-71. PubMed ID: 3508492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The isolation of Vibrio cholerae strains that produce cholera toxin and its B-subunit].
    Smirnova NI; Livanova LF; Davydova NI; Gintsburg AL; Il'ina TS
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):30-5. PubMed ID: 8067088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.
    Lange S; Holmgren J
    Acta Pathol Microbiol Scand C; 1978 Aug; 86C(4):145-52. PubMed ID: 696335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vibrio eltor strain, serotype Ogawa, the producer of cholera enterotoxin].
    Saiamov RM; Avrorov VP; Khanum'ian TA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):40-2. PubMed ID: 6342310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative evaluation of Vibrio cholerae colonization and lymphocyte count in small intestine villi of rabbits immunized with vibrio and cholera toxin].
    Efremov VE; Polotskiĭ IuE; Samostrel'skiĭ AIu; Vasser NR; Selivestrova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Feb; (2):63-70. PubMed ID: 7090657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-neutralization reactions of Escherichia coli and Vibrio cholerae enterotoxins as studied by rabbit skin inoculation test.
    Singh A; Mohan KS; Sethi SK; Vadehra DV
    Acta Microbiol Acad Sci Hung; 1977; 24(1):33-9. PubMed ID: 337760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
    Pierce NF; Cray WC; Engel PF
    Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral chemical vaccine made from a toxigenic strain of V. cholerae, Ogawa serovar (an experimental study)].
    Dzhaparidze MN; Karaeva LT; Sumarokov AA; Pavlova LP; Marchuk LM
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):62-8. PubMed ID: 506602
    [No Abstract]   [Full Text] [Related]  

  • 14. Promotion of colonization and virulence by cholera toxin is dependent on neutrophils.
    Queen J; Satchell KJ
    Infect Immun; 2013 Sep; 81(9):3338-45. PubMed ID: 23798539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease and immunity in cholera: a review.
    Holmgren J; Svennerholm AM
    J Infect Dis; 1977 Aug; 136 Suppl():S105-12. PubMed ID: 197173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of monoclonal antibodies that recognize the thermolabile toxin of Vibrio cholerae].
    González Garriga M; García Sánchez HM; Hermida Díaz C; Marcet Sánchez R; Monté Boada R
    Rev Cubana Med Trop; 1992; 44(3):185-7. PubMed ID: 9768213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of enterotoxin from Vibrio cholerae non-01.
    Hostacká A; Ciznár I; Korych B; Karolcek J
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):189-95. PubMed ID: 6193168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta.
    Ramamurthy T; Pal A; Bhattacharya MK; Bhattacharya SK; Chowdhury AS; Takeda Y; Takeda T; Pal SC; Nair GB
    Indian J Med Res; 1992 May; 95():125-9. PubMed ID: 1506061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.
    Bishop AL; Patimalla B; Camilli A
    Infect Immun; 2014 Jun; 82(6):2434-47. PubMed ID: 24686062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.